Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

The PERK Branch of the Unfolded Protein Response Promotes DLL4 Expression by Activating an Alternative Translation Mechanism.

Jaud M, Philippe C, Van Den Berghe L, Ségura C, Mazzolini L, Pyronnet S, Laurell H, Touriol C.

Cancers (Basel). 2019 Jan 25;11(2). pii: E142. doi: 10.3390/cancers11020142.

2.

Api5 a new cofactor of estrogen receptor alpha involved in breast cancer outcome.

Basset C, Bonnet-Magnaval F, Navarro MG, Touriol C, Courtade M, Prats H, Garmy-Susini B, Lacazette E.

Oncotarget. 2017 Apr 20;8(32):52511-52526. doi: 10.18632/oncotarget.17281. eCollection 2017 Aug 8.

3.

Long non-coding RNA expression profile in cytogenetically normal acute myeloid leukemia identifies a distinct signature and a new biomarker in NPM1-mutated patients.

De Clara E, Gourvest M, Ma H, Vergez F, Tosolini M, Dejean S, Demur C, Delabesse E, Recher C, Touriol C, Martelli MP, Falini B, Brousset P, Bousquet M.

Haematologica. 2017 Oct;102(10):1718-1726. doi: 10.3324/haematol.2017.171645. Epub 2017 Jul 4.

4.

Quantification of a Non-conventional Protein Secretion: The Low-Molecular-Weight FGF-2 Example.

Arcondéguy T, Touriol C, Lacazette E.

Methods Mol Biol. 2016;1459:127-34. doi: 10.1007/978-1-4939-3804-9_8.

PMID:
27665555
5.

Hypoxia and ER stress promote Staufen1 expression through an alternative translation mechanism.

Bonnet-Magnaval F, Philippe C, Van Den Berghe L, Prats H, Touriol C, Lacazette E.

Biochem Biophys Res Commun. 2016 Oct 14;479(2):365-371. doi: 10.1016/j.bbrc.2016.09.082. Epub 2016 Sep 17.

PMID:
27644878
6.

PERK mediates the IRES-dependent translational activation of mRNAs encoding angiogenic growth factors after ischemic stress.

Philippe C, Dubrac A, Quelen C, Desquesnes A, Van Den Berghe L, Ségura C, Filleron T, Pyronnet S, Prats H, Brousset P, Touriol C.

Sci Signal. 2016 May 3;9(426):ra44. doi: 10.1126/scisignal.aaf2753.

PMID:
27141928
7.

Key contribution of eIF4H-mediated translational control in tumor promotion.

Vaysse C, Philippe C, Martineau Y, Quelen C, Hieblot C, Renaud C, Nicaise Y, Desquesnes A, Pannese M, Filleron T, Escourrou G, Lawson M, Rintoul RC, Delisle MB, Pyronnet S, Brousset P, Prats H, Touriol C.

Oncotarget. 2015 Nov 24;6(37):39924-40. doi: 10.18632/oncotarget.5442.

8.

Glioblastoma invasion and cooption depend on IRE1α endoribonuclease activity.

Jabouille A, Delugin M, Pineau R, Dubrac A, Soulet F, Lhomond S, Pallares-Lupon N, Prats H, Bikfalvi A, Chevet E, Touriol C, Moenner M.

Oncotarget. 2015 Sep 22;6(28):24922-34. doi: 10.18632/oncotarget.4679.

9.

Blocking Tumor Necrosis Factor α Enhances CD8 T-cell-Dependent Immunity in Experimental Melanoma.

Bertrand F, Rochotte J, Colacios C, Montfort A, Tilkin-Mariamé AF, Touriol C, Rochaix P, Lajoie-Mazenc I, Andrieu-Abadie N, Levade T, Benoist H, Ségui B.

Cancer Res. 2015 Jul 1;75(13):2619-28. doi: 10.1158/0008-5472.CAN-14-2524. Epub 2015 May 14.

10.

Stabilization of the G-quadruplex at the VEGF IRES represses cap-independent translation.

Cammas A, Dubrac A, Morel B, Lamaa A, Touriol C, Teulade-Fichou MP, Prats H, Millevoi S.

RNA Biol. 2015;12(3):320-9. doi: 10.1080/15476286.2015.1017236.

11.

Reduced sphingosine kinase-1 and enhanced sphingosine 1-phosphate lyase expression demonstrate deregulated sphingosine 1-phosphate signaling in Alzheimer's disease.

Ceccom J, Loukh N, Lauwers-Cances V, Touriol C, Nicaise Y, Gentil C, Uro-Coste E, Pitson S, Maurage CA, Duyckaerts C, Cuvillier O, Delisle MB.

Acta Neuropathol Commun. 2014 Jan 27;2:12. doi: 10.1186/2051-5960-2-12.

12.

A role for eukaryotic initiation factor 4B overexpression in the pathogenesis of diffuse large B-cell lymphoma.

Horvilleur E, Sbarrato T, Hill K, Spriggs RV, Screen M, Goodrem PJ, Sawicka K, Chaplin LC, Touriol C, Packham G, Potter KN, Dirnhofer S, Tzankov A, Dyer MJ, Bushell M, MacFarlane M, Willis AE.

Leukemia. 2014 May;28(5):1092-102. doi: 10.1038/leu.2013.295. Epub 2013 Oct 18.

13.

E2F1 activates p53 transcription through its distal site and participates in apoptosis induction in HPV-positive cells.

Massip A, Arcondéguy T, Touriol C, Basset C, Prats H, Lacazette E.

FEBS Lett. 2013 Oct 1;587(19):3188-94. doi: 10.1016/j.febslet.2013.08.009. Epub 2013 Aug 13.

14.

Api5 contributes to E2F1 control of the G1/S cell cycle phase transition.

Garcia-Jove Navarro M, Basset C, Arcondéguy T, Touriol C, Perez G, Prats H, Lacazette E.

PLoS One. 2013 Aug 7;8(8):e71443. doi: 10.1371/journal.pone.0071443. Print 2013.

15.

VEGF-A mRNA processing, stability and translation: a paradigm for intricate regulation of gene expression at the post-transcriptional level.

Arcondéguy T, Lacazette E, Millevoi S, Prats H, Touriol C.

Nucleic Acids Res. 2013 Sep;41(17):7997-8010. doi: 10.1093/nar/gkt539. Epub 2013 Jul 12. Review.

16.

The nonlysosomal β-glucosidase GBA2 promotes endoplasmic reticulum stress and impairs tumorigenicity of human melanoma cells.

Sorli SC, Colié S, Albinet V, Dubrac A, Touriol C, Guilbaud N, Bedia C, Fabriàs G, Casas J, Ségui B, Levade T, Andrieu-Abadie N.

FASEB J. 2013 Feb;27(2):489-98. doi: 10.1096/fj.12-215152. Epub 2012 Oct 16.

PMID:
23073830
17.

A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients.

Griseri P, Bourcier C, Hieblot C, Essafi-Benkhadir K, Chamorey E, Touriol C, Pagès G.

Hum Mol Genet. 2011 Dec 1;20(23):4556-68. doi: 10.1093/hmg/ddr390. Epub 2011 Aug 29.

PMID:
21875902
18.

Adenosine triphosphatase pontin is overexpressed in hepatocellular carcinoma and coregulated with reptin through a new posttranslational mechanism.

Haurie V, Ménard L, Nicou A, Touriol C, Metzler P, Fernandez J, Taras D, Lestienne P, Balabaud C, Bioulac-Sage P, Prats H, Zucman-Rossi J, Rosenbaum J.

Hepatology. 2009 Dec;50(6):1871-83. doi: 10.1002/hep.23215.

19.

Pivotal role of translokin/CEP57 in the unconventional secretion versus nuclear translocation of FGF2.

Meunier S, Navarro MG, Bossard C, Laurell H, Touriol C, Lacazette E, Prats H.

Traffic. 2009 Dec;10(12):1765-72. doi: 10.1111/j.1600-0854.2009.00985.x. Epub 2009 Sep 14.

20.

Alternative-splicing-based bicistronic vectors for ratio-controlled protein expression and application to recombinant antibody production.

Fallot S, Ben Naya R, Hieblot C, Mondon P, Lacazette E, Bouayadi K, Kharrat A, Touriol C, Prats H.

Nucleic Acids Res. 2009 Nov;37(20):e134. doi: 10.1093/nar/gkp716. Epub 2009 Sep 3.

21.

The StkP/PhpP signaling couple in Streptococcus pneumoniae: cellular organization and physiological characterization.

Osaki M, Arcondéguy T, Bastide A, Touriol C, Prats H, Trombe MC.

J Bacteriol. 2009 Aug;191(15):4943-50. doi: 10.1128/JB.00196-09. Epub 2009 Jun 5.

22.

The VEGF IRESes are differentially susceptible to translation inhibition by miR-16.

Karaa ZS, Iacovoni JS, Bastide A, Lacazette E, Touriol C, Prats H.

RNA. 2009 Feb;15(2):249-54. doi: 10.1261/rna.1301109.

23.

An upstream open reading frame within an IRES controls expression of a specific VEGF-A isoform.

Bastide A, Karaa Z, Bornes S, Hieblot C, Lacazette E, Prats H, Touriol C.

Nucleic Acids Res. 2008 Apr;36(7):2434-45. doi: 10.1093/nar/gkn093. Epub 2008 Feb 26.

24.

TPM3-ALK expression induces changes in cytoskeleton organisation and confers higher metastatic capacities than other ALK fusion proteins.

Armstrong F, Lamant L, Hieblot C, Delsol G, Touriol C.

Eur J Cancer. 2007 Mar;43(4):640-6. Epub 2007 Feb 2.

PMID:
17276053
25.

Translational induction of VEGF internal ribosome entry site elements during the early response to ischemic stress.

Bornes S, Prado-Lourenco L, Bastide A, Zanibellato C, Iacovoni JS, Lacazette E, Prats AC, Touriol C, Prats H.

Circ Res. 2007 Feb 16;100(3):305-8. Epub 2007 Jan 25.

PMID:
17255526
26.

A "liaison dangereuse" between AUF1/hnRNPD and the oncogenic tyrosine kinase NPM-ALK.

Fawal M, Armstrong F, Ollier S, Dupont H, Touriol C, Monsarrat B, Delsol G, Payrastre B, Morello D.

Blood. 2006 Oct 15;108(8):2780-8. Epub 2006 Jul 11.

27.

Differential effects of X-ALK fusion proteins on proliferation, transformation, and invasion properties of NIH3T3 cells.

Armstrong F, Duplantier MM, Trempat P, Hieblot C, Lamant L, Espinos E, Racaud-Sultan C, Allouche M, Campo E, Delsol G, Touriol C.

Oncogene. 2004 Aug 12;23(36):6071-82.

PMID:
15208656
28.

Control of the vascular endothelial growth factor internal ribosome entry site (IRES) activity and translation initiation by alternatively spliced coding sequences.

Bornes S, Boulard M, Hieblot C, Zanibellato C, Iacovoni JS, Prats H, Touriol C.

J Biol Chem. 2004 Apr 30;279(18):18717-26. Epub 2004 Feb 5.

29.

Generation of protein isoform diversity by alternative initiation of translation at non-AUG codons.

Touriol C, Bornes S, Bonnal S, Audigier S, Prats H, Prats AC, Vagner S.

Biol Cell. 2003 May-Jun;95(3-4):169-78. Review.

PMID:
12867081
30.

Expression of the oncogenic NPM-ALK chimeric protein in human lymphoid T-cells inhibits drug-induced, but not Fas-induced apoptosis.

Greenland C, Touriol C, Chevillard G, Morris SW, Bai R, Duyster J, Delsol G, Allouche M.

Oncogene. 2001 Nov 1;20(50):7386-97.

31.

Increased yield of PCR products by addition of T4 gene 32 protein to the SMART PCR cDNA synthesis system.

Villalva C, Touriol C, Seurat P, Trempat P, Delsol G, Brousset P.

Biotechniques. 2001 Jul;31(1):81-3, 86.

32.

Molecular characterization of a new ALK translocation involving moesin (MSN-ALK) in anaplastic large cell lymphoma.

Tort F, Pinyol M, Pulford K, Roncador G, Hernandez L, Nayach I, Kluin-Nelemans HC, Kluin P, Touriol C, Delsol G, Mason D, Campo E.

Lab Invest. 2001 Mar;81(3):419-26.

PMID:
11310834
35.
37.
38.

Translation of CUG- but not AUG-initiated forms of human fibroblast growth factor 2 is activated in transformed and stressed cells.

Vagner S, Touriol C, Galy B, Audigier S, Gensac MC, Amalric F, Bayard F, Prats H, Prats AC.

J Cell Biol. 1996 Dec;135(5):1391-402.

39.

Deletion analysis of gene minE which encodes the topological specificity factor of cell division in Escherichia coli.

Pichoff S, Vollrath B, Touriol C, Bouché JP.

Mol Microbiol. 1995 Oct;18(2):321-9.

PMID:
8709851

Supplemental Content

Loading ...
Support Center